Login to Your Account



Study starts to tease out low-frequency cancer-causing mutations

By Sharon Kingman
Staff Writer

Tuesday, December 10, 2013
LONDON – The discovery of a gene that is mutated at a very low frequency in a range of cancers could lead to new therapeutic strategies to help treat many different cancers. Loss of function of the gene, which is called CUX1, appears to switch on a cell signaling pathway that promotes the growth of tumor cells. Although the percentage of patients with tumors that have CUX1 mutations is low, at about 1 percent, the numbers of patients that could be helped by therapies that aim to compensate for loss of CUX1 function could be high.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription